Header Logo

Connection

Robert Weinstein to Anti-Bacterial Agents

Back to Details
This is a "connection" page, showing publications Robert Weinstein has written about Anti-Bacterial Agents.
Robert Weinstein
Connection Strength
6.611
Anti-Bacterial Agents
  1. Computer-Assisted Antimicrobial Recommendations for Optimal Therapy: Analysis of Prescribing Errors in an Antimicrobial Stewardship Trial. Infect Control Hosp Epidemiol. 2017 07; 38(7):857-859.
    View in: PubMed
    Score: 0.464
  2. Betting the farm. J Hosp Med. 2016 05; 11(5):369-72.
    View in: PubMed
    Score: 0.423
  3. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. Infect Control Hosp Epidemiol. 2010 Oct; 31(10):1057-62.
    View in: PubMed
    Score: 0.292
  4. Lost in translation? Reliability of assessing inpatient antimicrobial appropriateness with use of computerized case vignettes. Infect Control Hosp Epidemiol. 2009 Feb; 30(2):163-71.
    View in: PubMed
    Score: 0.260
  5. An educational intervention to improve antimicrobial use in a hospital-based long-term care facility. J Am Geriatr Soc. 2007 Aug; 55(8):1236-42.
    View in: PubMed
    Score: 0.235
  6. Antibiotic cycling in intensive care units: the value of organized chaos? Crit Care Med. 2006 Feb; 34(2):549-51.
    View in: PubMed
    Score: 0.211
  7. Antimicrobial consumption data from pharmacy and nursing records: how good are they? Infect Control Hosp Epidemiol. 2005 Apr; 26(4):395-400.
    View in: PubMed
    Score: 0.200
  8. Q fever: a biological weapon in your backyard. Lancet Infect Dis. 2003 Nov; 3(11):709-21.
    View in: PubMed
    Score: 0.181
  9. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis. 2003 Jul 01; 37(1):59-64.
    View in: PubMed
    Score: 0.176
  10. Selective decontamination of the digestive tract: to stimulate or stifle? Intensive Care Med. 2003 May; 29(5):672-6.
    View in: PubMed
    Score: 0.175
  11. Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis. 2001 Nov; 41(3):149-54.
    View in: PubMed
    Score: 0.157
  12. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001 Mar-Apr; 7(2):188-92.
    View in: PubMed
    Score: 0.150
  13. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med. 2019 02 14; 380(7):638-650.
    View in: PubMed
    Score: 0.130
  14. Vancomycin-resistant enterococci: implications for surgeons. Surgery. 1999 Feb; 125(2):121-5.
    View in: PubMed
    Score: 0.130
  15. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med. 1998 Dec; 26(12):2001-4.
    View in: PubMed
    Score: 0.129
  16. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998 May 25; 158(10):1127-32.
    View in: PubMed
    Score: 0.124
  17. Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis. 1998 Feb; 177(2):378-82.
    View in: PubMed
    Score: 0.121
  18. Antimicrobial-coated central venous catheters--icing on the cake or the staff of life? Crit Care Med. 1998 Feb; 26(2):195-6.
    View in: PubMed
    Score: 0.121
  19. Aerosolized antimicrobials: another look. Crit Care Med. 1998 Jan; 26(1):5-6.
    View in: PubMed
    Score: 0.121
  20. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis. 1997 Apr; 24(4):704-6.
    View in: PubMed
    Score: 0.115
  21. The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2017 Mar 15; 64(suppl_1):S36-S40.
    View in: PubMed
    Score: 0.114
  22. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 2017 Feb 15; 215(suppl_1):S28-S36.
    View in: PubMed
    Score: 0.114
  23. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 1996 Dec 14; 348(9042):1615-9.
    View in: PubMed
    Score: 0.112
  24. Antibiotic Prophylaxis for Cesarean Delivery - When Broader Is Better. N Engl J Med. 2016 Sep 29; 375(13):1284-6.
    View in: PubMed
    Score: 0.111
  25. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1996 Sep 15; 125(6):448-56.
    View in: PubMed
    Score: 0.110
  26. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. Emerg Infect Dis. 2015 Nov; 21(11):2014-21.
    View in: PubMed
    Score: 0.104
  27. In memoriam: John P. Quinn, MD. Clin Infect Dis. 2014 Mar; 58(5):748-50.
    View in: PubMed
    Score: 0.091
  28. Drug use in infection control--is more less? Infection. 1993 May-Jun; 21(3):135-6.
    View in: PubMed
    Score: 0.087
  29. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013 Feb 01; 70(3):195-283.
    View in: PubMed
    Score: 0.086
  30. Continuation of high-dose vancomycin despite nephrotoxicity. Antimicrob Agents Chemother. 2012 Jun; 56(6):3470-1; author reply 3472.
    View in: PubMed
    Score: 0.082
  31. A multicenter retrospective study of childhood brucellosis in Chicago, Illinois from 1986 to 2008. Int J Infect Dis. 2011 Dec; 15(12):e812-7.
    View in: PubMed
    Score: 0.078
  32. Failure of infection control in intensive care units: can sucralfate improve the situation? Am J Med. 1991 Aug 08; 91(2A):132S-134S.
    View in: PubMed
    Score: 0.077
  33. Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis. 1990 Dec; 162(6):1393-7.
    View in: PubMed
    Score: 0.074
  34. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010 Apr; 31(4):341-7.
    View in: PubMed
    Score: 0.071
  35. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother. 2008 Sep; 52(9):3188-94.
    View in: PubMed
    Score: 0.063
  36. Acinetobacter infection. N Engl J Med. 2008 Mar 20; 358(12):1271-81.
    View in: PubMed
    Score: 0.061
  37. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics. Chemioterapia. 1987 Oct; 6(5):315-8.
    View in: PubMed
    Score: 0.059
  38. Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy. Diagn Microbiol Infect Dis. 2007 Aug; 58(4):491-4.
    View in: PubMed
    Score: 0.058
  39. Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2007 Jul; 45(7):2293-5.
    View in: PubMed
    Score: 0.058
  40. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007 Jan 15; 44(2):159-77.
    View in: PubMed
    Score: 0.056
  41. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006 Jun 01; 42(11):1552-60.
    View in: PubMed
    Score: 0.054
  42. Controlling antibiotic-resistant bacteria: what's an intensivist to do? Crit Care Med. 2005 Oct; 33(10):2446-7.
    View in: PubMed
    Score: 0.052
  43. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis. 2005 Jul; 24(7):443-9.
    View in: PubMed
    Score: 0.051
  44. Impact of a fluoroquinolone formulary change on acquisition of quinolone-resistant gram-negative bacilli. Eur J Clin Microbiol Infect Dis. 2005 Jun; 24(6):405-10.
    View in: PubMed
    Score: 0.050
  45. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis. 2005 Feb 01; 40(3):405-9.
    View in: PubMed
    Score: 0.049
  46. Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial. JAMA. 2023 10 10; 330(14):1337-1347.
    View in: PubMed
    Score: 0.045
  47. The role of the plasmid-mediated fluoroquinolone resistance genes as resistance mechanisms in pediatric infections due to Enterobacterales. Front Cell Infect Microbiol. 2023; 13:1249505.
    View in: PubMed
    Score: 0.045
  48. Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin Infect Dis. 2003 Mar 15; 36(6):724-30.
    View in: PubMed
    Score: 0.043
  49. Comparative in-vivo activity of Sch 29482 and six other extended spectrum cephalosporins. J Antimicrob Chemother. 1982 Feb; 9 Suppl C:41-8.
    View in: PubMed
    Score: 0.040
  50. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis. 2001 Dec; 1(5):314-25.
    View in: PubMed
    Score: 0.040
  51. Genomic Update of Phenotypic Prediction Rule for Methicillin-Resistant Staphylococcus aureus (MRSA) USA300 Discloses Jail Transmission Networks with Increased Resistance. Microbiol Spectr. 2021 09 03; 9(1):e0037621.
    View in: PubMed
    Score: 0.039
  52. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med. 1981 Feb; 70(2):449-54.
    View in: PubMed
    Score: 0.037
  53. A Multicentered Study of the Clinical and Molecular Epidemiology of TEM- and SHV-type Extended-Spectrum Beta-Lactamase Producing Enterobacterales Infections in Children. Pediatr Infect Dis J. 2021 01; 40(1):39-43.
    View in: PubMed
    Score: 0.037
  54. Reality check: how should we control antimicrobial use? Current practices and controversies. Infect Control Hosp Epidemiol. 2000 Dec; 21(12):792-5.
    View in: PubMed
    Score: 0.037
  55. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A. 1999 Jun 08; 96(12):6908-13.
    View in: PubMed
    Score: 0.033
  56. Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients. Clin Infect Dis. 2019 05 30; 68(12):2053-2059.
    View in: PubMed
    Score: 0.033
  57. Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012. J Pediatric Infect Dis Soc. 2019 May 11; 8(2):136-142.
    View in: PubMed
    Score: 0.033
  58. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis. 1999 Jan; 179(1):163-71.
    View in: PubMed
    Score: 0.032
  59. Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012. J Pediatric Infect Dis Soc. 2017 Nov 24; 6(4):352-359.
    View in: PubMed
    Score: 0.030
  60. Integrated genomic and interfacility patient-transfer data reveal the transmission pathways of multidrug-resistant Klebsiella pneumoniae in a regional outbreak. Sci Transl Med. 2017 Nov 22; 9(417).
    View in: PubMed
    Score: 0.030
  61. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis. 1996 Oct; 23(4):779-84.
    View in: PubMed
    Score: 0.028
  62. Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial. J Clin Microbiol. 2016 11; 54(11):2735-2742.
    View in: PubMed
    Score: 0.027
  63. Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial. Lancet Infect Dis. 2016 Jan; 16(1):70-79.
    View in: PubMed
    Score: 0.026
  64. Control of nosocomial infections in an intensive care unit in Guatemala City. Clin Infect Dis. 1995 Sep; 21(3):588-93.
    View in: PubMed
    Score: 0.026
  65. Infection control and pneumonia prophylaxis strategies in the intensive care unit. Semin Respir Infect. 1990 Sep; 5(3):191-203.
    View in: PubMed
    Score: 0.018
  66. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008 Mar 15; 46(6):787-94.
    View in: PubMed
    Score: 0.015
  67. Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med. 1985 Oct; 145(10):1804-7.
    View in: PubMed
    Score: 0.013
  68. Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. J Infect Dis. 1985 Oct; 152(4):769-74.
    View in: PubMed
    Score: 0.013
  69. Pseudomonas in the sinks in an intensive care unit: relation to patients. J Clin Pathol. 1984 Apr; 37(4):424-7.
    View in: PubMed
    Score: 0.012
  70. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. 2004 Feb; 18(2):99-107.
    View in: PubMed
    Score: 0.012
  71. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother. 1983 Apr; 11(4):299-310.
    View in: PubMed
    Score: 0.011
  72. Coisolation of Streptococcus pneumoniae and Hameophilus influenzae from middle ear fluid and sputum: effect on MIC results. J Clin Microbiol. 1999 Jan; 37(1):277.
    View in: PubMed
    Score: 0.008
  73. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA. 1996 Jan 17; 275(3):234-40.
    View in: PubMed
    Score: 0.007
  74. Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11. J Clin Microbiol. 1982 Aug; 16(2):266-70.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.